|
Volumn 95, Issue 12, 2002, Pages 831-832
|
Paracetamol: Balancing risk against benefit [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCYSTEINE;
ACETYLSALICYLIC ACID;
ANALGESIC AGENT;
ANTIDOTE;
CYCLOOXYGENASE 2 INHIBITOR;
IBUPROFEN;
NON PRESCRIPTION DRUG;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
ANALGESIA;
AUSTRALIA;
CLINICAL STUDY;
DEATH;
DENMARK;
DRUG INTOXICATION;
DRUG MARKETING;
DRUG OVERDOSE;
DRUG PACKAGING;
DRUG SAFETY;
DRUG SELECTIVITY;
DRUG USE;
GASTROINTESTINAL DISEASE;
HOSPITAL ADMISSION;
HUMAN;
KIDNEY DISEASE;
LEGAL ASPECT;
LETTER;
LIVER DISEASE;
MEDICAL DECISION MAKING;
MEDICAL INFORMATION SYSTEM;
MORTALITY;
PRESCRIPTION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
RISK BENEFIT ANALYSIS;
TELEPHONE;
UNITED KINGDOM;
|
EID: 0036924793
PISSN: 14602725
EISSN: None
Source Type: Journal
DOI: 10.1093/qjmed/95.12.831 Document Type: Letter |
Times cited : (6)
|
References (7)
|